Chapter 11

Role of APP in the Pathophysiology of Down Syndrome and Alzheimer’s Disease

Kumar Sambamurti, Miguel A. Pappolla, Debomoy K. Lahiri, Nigel H. Greig, Panneerselvam Chinnakannu, Ann-Charlotte Granholm and Vasudevaraju Padmaraju


Trisomy of chromosome 21 (Ts21), with duplication of one copy of all its genes to increase its copy number by 0.5-fold, is well tolerated, allowing the birth of live children. However, subjects with Ts21 suffer a spectrum of problems, including intellectual disability, skeletal deformity, and a number of secondary conditions such as defects in the visual system, hearing loss, cardiovascular disease, and a progressive dementia similar to Alzheimer’s disease (AD). In this chapter, we discuss the genotypephenotype relationships and identify the role played by individual genes. We also detail the role of the amyloid β (A4) precursor protein causing AD in Ts21 individuals.

Total Pages: 249-272 (24)

Purchase Chapter  Book Details


.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Frontiers in Clinical Drug Research-Dementia.
.Advances in Alzheimer Research.
.Recent Advances in the Treatment of Neurodegenerative Disorders.
.Advances in Alzheimer Research.
.Cellular and Molecular Biology of Autism Spectrum Disorders.